Top Markets
Coin of the day
Jia Jie Biomedical Co., Ltd. Jia Jie Biomedical Co., Ltd.

Jia Jie Biomedical Co., Ltd.

4109
Rangering i aksjer #26206
Jia Jie Biomedical Co., Ltd., headquartered in Kaohsiung, Taiwan, was... Jia Jie Biomedical Co., Ltd., headquartered in Kaohsiung, Taiwan, was established in 1995. Formerly known as Murad Chia Jei Biotechnology Co., Ltd. until its rebranding in June 2019, the company primarily specializes in the production and distribution of health foods and wellness products across both Taiwan and Mainland China. The company's core operations encompass the processing, sale, and trade of softshell turtle-derived food items, as well as the manufacturing of dairy products. Its diversified food portfolio also features a range of specialty items such as softshell turtle egg powder capsules, enzyme powders, tortoise jelly, softshell turtle oil, and various other encapsulated nutritional supplements. Beyond its food production, Jia Jie Biomedical engages in comprehensive import/export activities, product distribution, and managing bidding and quotation procedures for its offerings. It also operates as a wholesaler for a broad array of consumer goods, including non-alcoholic beverages, confectioneries, baked goods, dietary supplements, general groceries, everyday household items, and cosmetics. Further expanding its business scope, the company manufactures water purification systems and their associated components, provides brokerage services for life and property insurance, and invests in the research, development, and production of advanced aquatic product technologies and various biological solutions.
Aksjekurs
$0.35773906
Markedsverdi
$42.48M
Endring (1 dag)
0.00%
Endring (1 år)
-40.12%
Land
TW
Handel Jia Jie Biomedical Co., Ltd. (4109)
P/E-forhold for Jia Jie Biomedical Co., Ltd. (4109)
P/E-forhold per 2026 TTM: 0
Ifølge Jia Jie Biomedical Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for Jia Jie Biomedical Co., Ltd. fra 2026 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
Ikke nok data for de angitte datoene.
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
28.03 -
CH
- -
FR
- -
JP
75.87 -
IN
- -
BR
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.